Arguments for a different regulatory categorization and framework for stromal vascular fraction

Ricardo L. Rodriguez, Trivia Frazier, Bruce A. Bunnell, Cecilia A. Mouton, Keith L. March, Adam J. Katz, J. Peter Rubin, Ramon Llull, Jens A. Sørensen, Jeffrey M. Gimble

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Although adipose tissue and cells show considerable promise for clinical translation in the emerging field of regenerative medicine, they present a challenge to the regulatory community both nationally and internationally. This commentary evaluates the status of adipose-derived therapeutics and considers regulatory approaches designed to maximize patient safety while advancing clinical translation in accordance with evidence-based medical science.

Original languageEnglish
Pages (from-to)257-262
Number of pages6
JournalStem Cells and Development
Volume29
Issue number5
DOIs
StatePublished - 1 Mar 2020

Keywords

  • adipose-derived stromal/stem cells
  • cell therapy
  • regenerative medicine
  • regulation
  • stromal vascular fraction cells

Fingerprint Dive into the research topics of 'Arguments for a different regulatory categorization and framework for stromal vascular fraction'. Together they form a unique fingerprint.

  • Cite this

    Rodriguez, R. L., Frazier, T., Bunnell, B. A., Mouton, C. A., March, K. L., Katz, A. J., Rubin, J. P., Llull, R., Sørensen, J. A., & Gimble, J. M. (2020). Arguments for a different regulatory categorization and framework for stromal vascular fraction. Stem Cells and Development, 29(5), 257-262. https://doi.org/10.1089/scd.2019.0096